Microbiome and E. coli O157:H7 infection of human gut tissue
人体肠道组织的微生物组和大肠杆菌 O157:H7 感染
基本信息
- 批准号:9764263
- 负责人:
- 金额:$ 40.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-15 至 2022-07-31
- 项目状态:已结题
- 来源:
- 关键词:ActinsAcute Kidney FailureAdultAnimal ModelAnimalsAntibiotic TherapyAntibioticsBacteriaBacteriophagesBiological ModelsChildClustered Regularly Interspaced Short Palindromic RepeatsComplicationDNADiseaseDisease OutcomeDisease ProgressionEnvironmentEpithelialEscherichia coliEscherichia coli EHECEscherichia coli InfectionsEscherichia coli O157:H7F-ActinGenetic EngineeringGerm-FreeHealthHemolytic-Uremic SyndromeHemorrhagic colitisHourHumanIn VitroIncidenceIndividualInfectionInflammationInjectionsIntegration Host FactorsIntestinesKnowledgeLifeLytic PhaseModelingMucous body substanceMusOrganoidsOutcomePathogenicityPatientsPre-Clinical ModelPredispositionProcessProductionRageReportingResistanceRoleSafetySeverity of illnessShiga ToxinSourceStainsStem cellsSurface AntigensSystemTechnologyTestingTherapeuticTherapeutic InterventionTissue ModelTissue SampleTissuesTranslatingUp-RegulationVirulence Factorscommensal bacteriaembryonic stem cellexperiencefoodborne illnessgut microbiotahuman diseasehuman pathogenhuman tissuemicrobialmicrobial hostmicrobiomemicrobiome alterationmicroorganism interactionpathogenpathogenic Escherichia colipathogenic bacteriapreventresident commensalsresponsestem cell biology
项目摘要
Project Summary/Abstract
Shiga toxin producing E. coli (STEC), including O157:H7, are a leading cause of food-borne illnesses,
causing about 100,000 cases of watery and bloody diarrhea annually in the US. About 10% of cases progress
to the life-threatening complication, hemolytic uremic syndrome (HUS). For reasons that are not clear, young
children are more likely to develop HUS than adults, and HUS is the most common cause of acute kidney
failure in children. Currently there is no treatment for STEC. Furthermore, antibiotics induce STEC to produce
higher quantities of Shiga toxin, and antibiotic treatment is associated with increased incidence of severe
disease.
A serious limitation has been the lack of good animal models. Mice are not susceptible to STEC or
Shiga toxin when introduced into the intestinal tract. We have now shown that stem cell derived ‘induced
human intestinal organoids’ (iHIOs) are sensitive to E. coli O157:H7 and Shiga toxin, and thus represents the
first tractable model system to study human disease. This proposal will test the hypotheses that iHIOs can be
used to identify microbial and host factors that influence infection by STEC:
Aim 1 will test role of antibiotics in preventing or enhancing disease.
Aim 2 will examine the role of the microbiome in influencing disease progression.
Aim 3 will determine if agents reported to down-regulate O157:H7 virulence factor expression can
impact disease outcome by preventing intestinal damage.
These studies will increase our understanding of human STEC infection and could provide a simple
experimental system to assess potential therapeutic interventions for safety and efficacy in humans.
项目摘要/摘要
产生志贺毒素的大肠杆菌(STEC),包括O157:H7,是导致食源性疾病的主要原因,
每年在美国造成大约10万例水样和血性腹泻。约10%的案件进展
对于危及生命的并发症--溶血性尿毒症综合征(HUS)。原因不清楚,年轻人
儿童比成人更容易患上HUS,HUS是急性肾脏病最常见的原因
孩子们的失败。目前还没有治疗STEC的方法。此外,抗生素诱导STEC产生
较高数量的志贺毒素,和抗生素治疗与增加严重的
疾病。
一个严重的限制是缺乏好的动物模型。小鼠不容易感染STEC或
志贺毒素进入肠道时。我们现在已经证明了干细胞来源的‘诱导
人类肠道有机化合物(IHIO)对O157:H7和志贺毒素敏感,因此代表了
第一个研究人类疾病的易于处理的模型系统。这项提议将检验iHIO可以是
用于确定影响STEC感染的微生物和宿主因素:
目标1将测试抗生素在预防或增强疾病方面的作用。
目标2将研究微生物组在影响疾病进展中的作用。
AIM 3将确定被报道下调O157:H7毒力因子表达的药物是否可以
通过预防肠道损伤来影响疾病结局。
这些研究将增加我们对人类STEC感染的了解,并可能提供一种简单的
评估潜在的治疗干预措施对人类的安全性和有效性的实验系统。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alison A. Weiss其他文献
198 - Human Pluripotent Stem Cell-Derived Intestinal Organoid Model for the Study of Human Responses to Infection Shiga Toxin Producing <em>Escherichia Coli</em>-Induced Pathogenesis
- DOI:
10.1016/s0016-5085(17)30549-8 - 发表时间:
2017-04-01 - 期刊:
- 影响因子:
- 作者:
Suman Pradhan;Sayali Karve;Alison A. Weiss - 通讯作者:
Alison A. Weiss
Alison A. Weiss的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alison A. Weiss', 18)}}的其他基金
Microbiome and E. coli O157:H7 infection of human gut tissue
人体肠道组织的微生物组和大肠杆菌 O157:H7 感染
- 批准号:
10208643 - 财政年份:2018
- 资助金额:
$ 40.13万 - 项目类别:
Shiga toxin activity in human intestinal organoids
人类肠道类器官中志贺毒素的活性
- 批准号:
9035240 - 财政年份:2016
- 资助金额:
$ 40.13万 - 项目类别:
Intestinal Organoids as a model system for studying enteric disease
肠类器官作为研究肠道疾病的模型系统
- 批准号:
9230327 - 财政年份:2015
- 资助金额:
$ 40.13万 - 项目类别:
Intestinal Organoids as a model system for studying enteric disease
肠类器官作为研究肠道疾病的模型系统
- 批准号:
8856069 - 财政年份:2015
- 资助金额:
$ 40.13万 - 项目类别:
Shiga Toxin Production and Role in Pathogenesis
志贺毒素的产生及其在发病机制中的作用
- 批准号:
7577388 - 财政年份:2007
- 资助金额:
$ 40.13万 - 项目类别:
Glycoconjugate based diagnostics for bacterial toxins
基于糖缀合物的细菌毒素诊断
- 批准号:
7325412 - 财政年份:2007
- 资助金额:
$ 40.13万 - 项目类别:
Shiga Toxin Production and Role in Pathogenesis
志贺毒素的产生及其在发病机制中的作用
- 批准号:
7364590 - 财政年份:2007
- 资助金额:
$ 40.13万 - 项目类别:
Glycoconjugate based diagnostics for bacterial toxins
基于糖缀合物的细菌毒素诊断
- 批准号:
7678970 - 财政年份:2007
- 资助金额:
$ 40.13万 - 项目类别:
Shiga Toxin Production and Role in Pathogenesis
志贺毒素的产生及其在发病机制中的作用
- 批准号:
7262869 - 财政年份:2007
- 资助金额:
$ 40.13万 - 项目类别:
Glycoconjugate based diagnostics for bacterial toxins
基于糖缀合物的细菌毒素诊断
- 批准号:
7475806 - 财政年份:2007
- 资助金额:
$ 40.13万 - 项目类别:
相似海外基金
Acute kidney failure: investigation and treatment of ki dney cell injury
急性肾衰竭:肾细胞损伤的调查和治疗
- 批准号:
nhmrc : 901011 - 财政年份:1990
- 资助金额:
$ 40.13万 - 项目类别:
NHMRC Project Grants
Acute kidney failure: new methods of investigation and treatment
急性肾衰竭:研究和治疗的新方法
- 批准号:
nhmrc : 891081 - 财政年份:1989
- 资助金额:
$ 40.13万 - 项目类别:
NHMRC Project Grants